|Bid||11.12 x 164500|
|Ask||11.23 x 470300|
|Day's range||11.01 - 11.43|
|52-week range||10.05 - 14.09|
|Beta (3Y monthly)||1.39|
|PE ratio (TTM)||15.70|
|Forward dividend & yield||0.22 (1.89%)|
|1y target est||10.83|
On the 14 December 2018, Ryman Healthcare Limited (NZSE:RYM) will be paying shareholders an upcoming dividend amount of NZ$0.11 per share. However, investors must have bought the company’s stock before Read More...
In this article I am going to calculate the intrinsic value of Ryman Healthcare Limited (NZSE:RYM) by taking the foreast future cash flows of the company and discounting them back Read More...
When Ryman Healthcare Limited (NZSE:RYM) released its most recent earnings update (31 March 2018), I compared it against two factor: its historical earnings track record, and the performance of its Read More...
Ryman Healthcare Limited’s (NZSE:RYM) latest earnings announcement in March 2018 confirmed that the business experienced a small tailwind, eventuating to a single-digit earnings growth of 8.8%. Below, I’ve laid out Read More...
Today, I will be analyzing Ryman Healthcare Limited’s (NZSE:RYM) recent ownership structure, an important but not-so-popular subject among individual investors. A company’s ownership structure is often linked to its shareRead More...
Ryman Healthcare Limited (NZSE:RYM) delivered an ROE of 20.01% over the past 12 months, which is an impressive feat relative to its industry average of 12.81% during the same period.Read More...